Oracle and Ci4CC Partner to Accelerate Oncology Innovation
Go back to Oracle and Ci4CC Partner to Accelerate Oncology Innovation| Oracle Corp. (NYSE: ORCL) | Delayed: 140.20 -2.3 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.50 | 52 Week High | $42.00 | |||
| Open | $143.30 | 52 Week Low | $33.13 | |||
| Day High | $147.06 | P/E | 59.91 | |||
| Day Low | $138.83 | EPS | $2.34 | |||
| Volume | 33,082,195 | |||||
